Literature DB >> 18445594

Plasma membrane cholesterol content affects nitric oxide diffusion dynamics and signaling.

Shane Miersch1, Michael Graham Espey, Ruchi Chaube, Arzu Akarca, Rodney Tweten, Sirinart Ananvoranich, Bulent Mutus.   

Abstract

Nitric oxide (NO) signaling is inextricably linked to both its physical and chemical properties. Due to its preferentially hydrophobic solubility, NO molecules tend to partition from the aqueous milieu into biological membranes. We hypothesized that plasma membrane ordering provided by cholesterol further couples the physics of NO diffusion with cellular signaling. Fluorescence lifetime quenching studies with pyrene liposome preparations showed that the presence of cholesterol decreased apparent diffusion coefficients of NO approximately 20-40%, depending on the phospholipid composition. Electrochemical measurements indicated that the diffusion rate of NO across artificial bilayer membranes were inversely related to cholesterol content. Sterol transport-defective Niemann-Pick type C1 (NPC1) fibroblasts exhibited increased plasma membrane cholesterol content but decreased activation of both intracellular soluble guanylyl cyclase and vasodilator-stimulated phosphoprotein (VASP) phosphorylation at Ser(239) induced by exogenous NO exposure relative to their normal human fibroblast (NHF) counterparts. Augmentation of plasma membrane cholesterol in NHF diminished production of both cGMP and VASP phosphorylation elicited by NO to NPC1-comparable levels. Conversely, decreasing membrane cholesterol in NPC1 resulted in the augmentation in both cGMP and VASP phosphorylation to a level similar to those observed in NHF. Increasing plasma membrane cholesterol contents in NHF, platelets, erythrocytes and tumor cells also resulted in an increased level of extracellular diaminofluorescein nitrosation following NO exposure. These findings suggest that the impact of cholesterol on membrane fluidity and microdomain structure contributes to the spatial heterogeneity of NO diffusion and signaling.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18445594      PMCID: PMC2441544          DOI: 10.1074/jbc.M800440200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  59 in total

Review 1.  The receptor-like properties of nitric oxide-activated soluble guanylyl cyclase in intact cells.

Authors:  Tomas C Bellamy; John Garthwaite
Journal:  Mol Cell Biochem       Date:  2002-01       Impact factor: 3.396

Review 2.  Ena/VASP proteins: regulators of the actin cytoskeleton and cell migration.

Authors:  Matthias Krause; Erik W Dent; James E Bear; Joseph J Loureiro; Frank B Gertler
Journal:  Annu Rev Cell Dev Biol       Date:  2003       Impact factor: 13.827

3.  Distinction between nitrosating mechanisms within human cells and aqueous solution.

Authors:  M G Espey; K M Miranda; D D Thomas; D A Wink
Journal:  J Biol Chem       Date:  2001-06-12       Impact factor: 5.157

4.  Dynamic association of nitric oxide downstream signaling molecules with endothelial caveolin-1 in rat aorta.

Authors:  A Elizabeth Linder; Lynnette P McCluskey; Kenneth R Cole; Katherine M Lanning; R Clinton Webb
Journal:  J Pharmacol Exp Ther       Date:  2005-03-18       Impact factor: 4.030

5.  Cholesterol organization in membranes at low concentrations: effects of curvature stress and membrane thickness.

Authors:  R Rukmini; S S Rawat; S C Biswas; A Chattopadhyay
Journal:  Biophys J       Date:  2001-10       Impact factor: 4.033

6.  Use of cyclodextrins for manipulating cellular cholesterol content.

Authors:  A E Christian; M P Haynes; M C Phillips; G H Rothblat
Journal:  J Lipid Res       Date:  1997-11       Impact factor: 5.922

7.  The kinetics of the reaction between NO and O2 as studied by a novel approach.

Authors:  S Caccia; I Denisov; M Perrella
Journal:  Biophys Chem       Date:  1999-01-11       Impact factor: 2.352

8.  Models of the diffusional spread of nitric oxide: implications for neural nitric oxide signalling and its pharmacological properties.

Authors:  J Wood; J Garthwaite
Journal:  Neuropharmacology       Date:  1994-11       Impact factor: 5.250

9.  Iron nitrosyl complexes as models for biological nitric oxide transfer reagents.

Authors:  Chao-Yi Chiang; Marcetta Y Darensbourg
Journal:  J Biol Inorg Chem       Date:  2006-03-07       Impact factor: 3.358

10.  Phosphoinositide 3-kinase-independent non-genomic signals transit from the androgen receptor to Akt1 in membrane raft microdomains.

Authors:  Bekir Cinar; Nishit K Mukhopadhyay; Gaoyuan Meng; Michael R Freeman
Journal:  J Biol Chem       Date:  2007-07-16       Impact factor: 5.157

View more
  19 in total

1.  Two functionally distinct pools of eNOS in endothelium are facilitated by myoendothelial junction lipid composition.

Authors:  Lauren A Biwer; Evan P Taddeo; Brandon M Kenwood; Kyle L Hoehn; Adam C Straub; Brant E Isakson
Journal:  Biochim Biophys Acta       Date:  2016-04-19

Review 2.  Metabolic Dysfunction in Parkinson's Disease: Bioenergetics, Redox Homeostasis and Central Carbon Metabolism.

Authors:  Annadurai Anandhan; Maria S Jacome; Shulei Lei; Pablo Hernandez-Franco; Aglaia Pappa; Mihalis I Panayiotidis; Robert Powers; Rodrigo Franco
Journal:  Brain Res Bull       Date:  2017-03-21       Impact factor: 4.077

Review 3.  Subcellular and cellular locations of nitric oxide synthase isoforms as determinants of health and disease.

Authors:  Cleva Villanueva; Cecilia Giulivi
Journal:  Free Radic Biol Med       Date:  2010-04-11       Impact factor: 7.376

Review 4.  Antioxidant gene therapy against neuronal cell death.

Authors:  Juliana Navarro-Yepes; Laura Zavala-Flores; Annadurai Anandhan; Fang Wang; Maciej Skotak; Namas Chandra; Ming Li; Aglaia Pappa; Daniel Martinez-Fong; Luz Maria Del Razo; Betzabet Quintanilla-Vega; Rodrigo Franco
Journal:  Pharmacol Ther       Date:  2013-12-12       Impact factor: 12.310

Review 5.  Oxidative stress, redox signaling, and autophagy: cell death versus survival.

Authors:  Juliana Navarro-Yepes; Michaela Burns; Annadurai Anandhan; Oleh Khalimonchuk; Luz Maria del Razo; Betzabet Quintanilla-Vega; Aglaia Pappa; Mihalis I Panayiotidis; Rodrigo Franco
Journal:  Antioxid Redox Signal       Date:  2014-03-24       Impact factor: 8.401

6.  Serum starvation of ARPE-19 changes the cellular distribution of cholesterol and Fibulin3 in patterns reminiscent of age-related macular degeneration.

Authors:  Dinusha Rajapakse; Katherine Peterson; Sanghamitra Mishra; Graeme Wistow
Journal:  Exp Cell Res       Date:  2017-10-31       Impact factor: 3.905

7.  Ezetimibe is an inhibitor of tumor angiogenesis.

Authors:  Keith R Solomon; Kristine Pelton; Kelly Boucher; Jinsoo Joo; Christopher Tully; David Zurakowski; Carl P Schaffner; Jayoung Kim; Michael R Freeman
Journal:  Am J Pathol       Date:  2009-01-29       Impact factor: 4.307

8.  Effect of nitric oxide on the anticancer activity of the topoisomerase-active drugs etoposide and adriamycin in human melanoma cells.

Authors:  Birandra K Sinha; Ashutosh Kumar; Suchandra Bhattacharjee; Michael G Espey; Ronald P Mason
Journal:  J Pharmacol Exp Ther       Date:  2013-09-18       Impact factor: 4.030

9.  Cholesterol induces renal vasoconstriction and anti-natriuresis by inhibiting nitric oxide production in anesthetized rats.

Authors:  Libor Kopkan; Md Abdul H Khan; Agnieszka Lis; Mouhamed S Awayda; Dewan S A Majid
Journal:  Am J Physiol Renal Physiol       Date:  2009-09-23

10.  Deficiency of niemann-pick type C-1 protein impairs release of human immunodeficiency virus type 1 and results in Gag accumulation in late endosomal/lysosomal compartments.

Authors:  Yuyang Tang; Ihid Carneiro Leao; Ebony M Coleman; Robin Shepard Broughton; James E K Hildreth
Journal:  J Virol       Date:  2009-05-27       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.